#nephmadness — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #nephmadness, aggregated by home.social.
-
whoah whoah whoah.....non-IS in IgAN...just as all the IS trials are dropping like TESTING, NEFIGARD and more to come?
What do you say @Bneuen and @ChristosArgyrop - team #flozinator or team #immunosuppression?
I think flozins have had their time in the spotlight - time to let IS come ahead?
-
WTF here though? #Finerenone over good old spironolactone?
New drugs - and a BRP clean sweep! Who would have seen this coming?
-
From https://ajkdblog.org/2023/03/01/nephmadness-2023-iga-nephropathy-region/ by Dilushi Wijay - this MEST-C #VisualAbstract is 💥
-
From https://ajkdblog.org/2023/03/01/nephmadness-2023-iga-nephropathy-region/ by Dilushi Wijay - this MEST-C #VisualAbstract is 💥
-
From https://ajkdblog.org/2023/03/01/nephmadness-2023-iga-nephropathy-region/ by Dilushi Wijay - this MEST-C #VisualAbstract is 💥
-
From https://ajkdblog.org/2023/03/01/nephmadness-2023-iga-nephropathy-region/ by Dilushi Wijay - this MEST-C #VisualAbstract is 💥
-
From https://ajkdblog.org/2023/03/01/nephmadness-2023-iga-nephropathy-region/ by Dilushi Wijay - this MEST-C #VisualAbstract is 💥
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505